Unraveling  ||| S:0 E:11 ||| VBG
the  ||| S:11 E:15 ||| DT
links  ||| S:15 E:21 ||| NNS
between  ||| S:21 E:29 ||| IN
cancer  ||| S:29 E:36 ||| NN
and  ||| S:36 E:40 ||| CC
aging  ||| S:40 E:46 ||| VBG
Aging  ||| S:46 E:52 ||| NNP
is ||| S:52 E:54 ||| VBZ
,  ||| S:54 E:56 ||| ,
by  ||| S:56 E:59 ||| IN
far ||| S:59 E:62 ||| RB
,  ||| S:62 E:64 ||| ,
the  ||| S:64 E:68 ||| DT
most  ||| S:68 E:73 ||| RBS
important  ||| S:73 E:83 ||| JJ
risk  ||| S:83 E:88 ||| NN
factor  ||| S:88 E:95 ||| NN
for  ||| S:95 E:99 ||| IN
cancer ||| S:99 E:105 ||| NN
;  ||| S:105 E:107 ||| :
however ||| S:107 E:114 ||| RB
,  ||| S:114 E:116 ||| ,
only  ||| S:116 E:121 ||| RB
very  ||| S:121 E:126 ||| RB
recently  ||| S:126 E:135 ||| RB
the  ||| S:135 E:139 ||| DT
mechanistic  ||| S:139 E:151 ||| JJ
links  ||| S:151 E:157 ||| NNS
between  ||| S:157 E:165 ||| IN
these  ||| S:165 E:171 ||| DT
two  ||| S:171 E:175 ||| CD
processes  ||| S:175 E:185 ||| NNS
are  ||| S:185 E:189 ||| VBP
beginning  ||| S:189 E:199 ||| VBG
to  ||| S:199 E:202 ||| TO
emerge ||| S:202 E:208 ||| VB
.  ||| S:208 E:210 ||| .
To  ||| S:210 E:213 ||| TO
approach  ||| S:213 E:222 ||| VB
the  ||| S:222 E:226 ||| DT
connection  ||| S:226 E:237 ||| NN
between  ||| S:237 E:245 ||| IN
aging  ||| S:245 E:251 ||| VBG
and  ||| S:251 E:255 ||| CC
cancer ||| S:255 E:261 ||| NN
,  ||| S:261 E:263 ||| ,
it  ||| S:263 E:266 ||| PRP
is  ||| S:266 E:269 ||| VBZ
helpful  ||| S:269 E:277 ||| JJ
to  ||| S:277 E:280 ||| TO
re-phrase  ||| S:280 E:290 ||| VB
the  ||| S:290 E:294 ||| DT
link  ||| S:294 E:299 ||| NN
as  ||| S:299 E:302 ||| RB
follows ||| S:302 E:309 ||| VBZ
:  ||| S:309 E:311 ||| :
the  ||| S:311 E:315 ||| DT
best  ||| S:315 E:320 ||| JJS
protection  ||| S:320 E:331 ||| NN
against  ||| S:331 E:339 ||| IN
cancer  ||| S:339 E:346 ||| NN
is  ||| S:346 E:349 ||| VBZ
to  ||| S:349 E:352 ||| TO
be  ||| S:352 E:355 ||| VB
young ||| S:355 E:360 ||| JJ
.  ||| S:360 E:362 ||| .
Therefore ||| S:362 E:371 ||| RB
,  ||| S:371 E:373 ||| ,
longevity  ||| S:373 E:383 ||| JJ
genes  ||| S:383 E:389 ||| NNS
and  ||| S:389 E:393 ||| CC
longevity  ||| S:393 E:403 ||| JJ
interventions  ||| S:403 E:417 ||| NNS
should  ||| S:417 E:424 ||| MD
be  ||| S:424 E:427 ||| VB
cancer  ||| S:427 E:434 ||| NN
protecting ||| S:434 E:444 ||| VBG
.  ||| S:444 E:446 ||| .
